By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ArQule, Inc. 

19 Presidential Way

Woburn  Massachusetts  01801  U.S.A.
Phone: 781-994-0300 Fax: 781-376-6019


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Discovery

Collaborations

Roche 

Pfizer 

Daiichi Sankyo, Inc. 





Company News
ArQule, Inc. (ARQL) Announces Interim Phase II Study Results For Tivantinib In Combination With Cetuximab In Patients With MET-High, KRAS Wild Type Colorectal Cancer Presented At ESMO World Congress On Gastrointestinal Cancer 2015 7/6/2015 7:42:31 AM
ArQule, Inc. (ARQL) Appoints Robert J. Weiskopf As Chief Financial Officer 6/1/2015 1:46:37 PM
ASCO15: ArQule, Inc. (ARQL) Announces Data Presentations With Tivantinib And ARQ 087 To Be Featured At ASCO 2015 6/1/2015 1:35:45 PM
ArQule, Inc. (ARQL) To Present At Jefferies and Co. 2015 Global Healthcare Conference 5/28/2015 10:46:24 AM
ArQule, Inc. (ARQL) Reports First Quarter 2015 Financial Results 5/6/2015 12:10:28 PM
ArQule, Inc. (ARQL) And Beryllium Announce Collaborative Research And Development Agreement 5/5/2015 8:51:07 AM
ArQule, Inc. (ARQL) To Report First Quarter 2015 Financial Results On May 6, 2015 4/29/2015 12:30:15 PM
ArQule, Inc. (ARQL) Announces Data Presentations With ARQ 087, Inhibitor Of FGFR, At AACR 4/21/2015 11:22:44 AM
ArQule, Inc. (ARQL) To Present at 14th Annual Needham Healthcare Conference 4/7/2015 10:54:30 AM
ArQule, Inc. (ARQL) Reports Fiscal 2014 Year End And Fourth Quarter Results 3/4/2015 11:17:44 AM
12345678910...
//-->